Deferred Tax Assets, Valuation Allowance of GeoVax Labs, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
GeoVax Labs, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • GeoVax Labs, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $36,783,772, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

GeoVax Labs, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $36,783,772 +$6,848,610 +23% 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q4 2023 $29,935,162 +$7,025,692 +31% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q4 2022 $22,909,470 +$2,725,013 +14% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $20,184,457 +$4,208,790 +26% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q4 2020 $15,975,667 -$2,811,563 -15% 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q4 2019 $18,787,230 -$1,092,724 -5.5% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q4 2018 $19,879,954 +$755,995 +4% 31 Dec 2018 10-K 24 Mar 2020 2019 FY
Q4 2017 $19,123,959 -$9,207,800 -32% 31 Dec 2017 10-K 26 Mar 2019 2018 FY
Q4 2016 $28,331,759 +$1,200,725 +4.4% 31 Dec 2016 10-K 23 Mar 2018 2017 FY
Q4 2015 $27,131,034 +$1,109,091 +4.3% 31 Dec 2015 10-K 24 Mar 2017 2016 FY
Q4 2014 $26,021,943 +$1,019,062 +4.1% 31 Dec 2014 10-K 16 Mar 2016 2015 FY
Q4 2013 $25,002,881 -$2,292,860 -8.4% 31 Dec 2013 10-K 20 Mar 2015 2014 FY
Q4 2012 $27,295,741 -$295,489 -1.1% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 $27,591,230 31 Dec 2011 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.